SERUM INSTITUTE OF INDIA PVT. LTD.
History
| Year | Detail |
|---|---|
| 1966 | Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals. |
| 2011 | Serum Institute of India Ltd. and Merck collaborated to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in emerging and developing countries worldwide. |
| 2012 | Serum Institute acquired Bilthoven Biologicals of the Netherlands to get access to technology and expertise for making the Injectable Polio Vaccine (Salk), which is possessed by only a few other vaccine manufacturing plants globally. |
| 2024 | Bharat Biotech, a company specializing in vaccine and biotherapeutic innovation, partnered with Bilthoven Biologicals B.V., a wholly owned subsidiary of Serum Institute, to further strengthen the production and supply security of Oral Polio Vaccines (OPV). |
| 2025 | Primrose Bio Inc., a company with proprietary manufacturing technologies for human therapeutics, collaborated with Serum Institute to develop a novel multi-antigen vaccine for infections that affect millions of people globally. |
BCC Research Beacon 